Corcept Therapeutics | CORT - Market Capitalization


Corcept Therapeutics reported $3.39B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
ANI Pharmaceuticals USD 1.77B 269M Dec/2025
Ardelyx USD 1.33B 390M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Canopy Growth CAD 781.35M 426.11M Sep/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Esperion Therapeutics USD 475M 410M Mar/2026
J&J USD 500.24B 67.44B Dec/2025
Knight Therapeutics CAD 624.22M 38.25M Mar/2026
Lexicon Pharmaceuticals USD 416M 2M Mar/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 246.07B 11.81B Sep/2025
Pacira USD 1.06B 94M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025